Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer, and it usually occurs following chronic liver disease. Although some progress has been made in the treatment of HCC, the prognosis of patients with advanced HCC is not optimistic, mainly because of the inevitable develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Lei, Li, Luan, Liu, Yongzhuang, Zhan, Meixiao, Lu, Ligong, Yuan, Shengtao, Liu, Yanyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987615/
https://www.ncbi.nlm.nih.gov/pubmed/36891274
http://dx.doi.org/10.3389/fphar.2023.1097277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987615/
https://www.ncbi.nlm.nih.gov/pubmed/36891274
http://dx.doi.org/10.3389/fphar.2023.1097277

Ejemplares similares